A critical overview of the current myofascial pain literature - July 2020

Jan Dommerholt1, Todd Hooks2, Jacob N Thorp3

  • 1Bethesda Physiocare, Bethesda, MD, USA; Myopain Seminars, Bethesda, MD, USA.

Insights

This literature overview covers myofascial pain and trigger point (TrP) research, including dry needling (DN) and manual therapies. The journal aims to catch up on publications after a missed issue, presenting a larger volume of reviewed articles.

Area of Science:

  • Pain Research
  • Musculoskeletal Disorders
  • Literature Review

Background:

  • This issue presents a comprehensive overview of recent literature on myofascial pain and trigger points (TrPs).
  • The journal experienced an administrative delay, resulting in a larger collection of reviewed articles in this edition to compensate for the missed January 2020 issue.
  • Dr. Li-Wei Chou is departing from his contributions to the literature overview due to increased work responsibilities.

Discussion:

  • The growing volume of published research on myofascial pain and TrPs presents a significant challenge for comprehensive coverage.
  • The current edition includes a diverse range of studies, encompassing basic research, reviews, dry needling (DN), acupuncture, injections, manual therapies, and other clinical approaches.
  • Dr. Chou's expertise in interpreting complex medical studies and including Chinese-language research has been invaluable.

Key Insights:

  • The overview features 10 basic research articles, 4 reviews, 14 articles on dry needling, acupuncture, and injections, 3 on manual therapies, and 4 on other clinical approaches.
  • The inclusion of varied study types provides a broad perspective on current advancements in myofascial pain and TrP management.
  • The journal acknowledges Dr. Chou's contributions and wishes him well in his future endeavors.

Outlook:

  • Future literature overviews will continue to navigate the expanding body of research in myofascial pain and trigger point management.
  • Efforts will be made to maintain a balanced and comprehensive review of diverse therapeutic modalities.
  • The journal team expresses gratitude for Dr. Chou's past contributions and anticipates potential future collaborations.

Related Concept Videos

Layers of Connective Tissue Proper01:21

Layers of Connective Tissue Proper

Fascia, a thin layer of fibrous connective tissue, is distributed throughout the body. It demarcates and forms a supportive covering over skeletal muscles, bones, blood vessels, and organs. There are three main types of facia— superficial fascia, deep fascia, and subserous fascia. These are all present at different depths in the body. Fascia reduces the friction and permits muscles, joints, and organs to easily slide against each other, facilitating movement of the body and preventing...
3.2K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Overview of Muscle Tissues01:25

Overview of Muscle Tissues

The human body has three types of muscle tissue: skeletal, smooth, and cardiac. Each class has unique properties that enable them to perform specific functions. However, all muscle tissues share certain properties, including elasticity, contractility, and excitability. 
Elasticity
Elasticity is the ability of muscles to stretch and return to their original shape. This property is partly due to elastic fibers — macromolecules that run through the muscles. These fibers are firm and...
20.6K
Peripherally and Centrally Acting Muscle Relaxants: A Comparison01:09

Peripherally and Centrally Acting Muscle Relaxants: A Comparison

Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
4.2K
Classification of Skeletal Muscle Fibers01:48

Classification of Skeletal Muscle Fibers

Skeletal muscles continuously produce ATP to provide the energy that enables muscle contractions. Skeletal muscle fibers can be categorized into three types based on differences in their contraction speed and how they produce ATP, as well as physical differences related to these factors. Most human muscles contain all three muscle fiber types, albeit in varying proportions.
Slow-Twitch Muscle Fibers
Slow oxidative, muscle fibers appear red due to large numbers of capillaries and high levels of...
59.1K
Classification of Skeletal Muscle Relaxants01:28

Classification of Skeletal Muscle Relaxants

Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.9K